SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is drawing heavy investor attention as the market anticipates a catalyst-heavy year, featuring three critical Phase 3 data readouts for its lead psychiatry program. While some community members voice concerns over potential share dilution and historical management turnover, bullish sentiment remains centered on the company's strong cash position and the regulatory potential for its novel LSD-based therapy in a massive total addressable market.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are surging following a Bloomberg report that the company is exploring strategic options, including a potential sale to a major media firm. The news has ignited significant community debate, with traders analyzing the stock's newfound momentum, the viability of various buyout candidates, and the potential for a larger breakout as institutional interest grows.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is currently facing significant selling pressure and volatility, with the community actively debating whether the stock's sluggish performance is a result of sector-wide headwinds, algorithmic trading, or a lack of visibility on contract value. While some investors are accumulating shares in anticipation of long-term upside from nuclear and government infrastructure projects, others remain frustrated by persistent late-day selloffs and limited price momentum.

WorldFinancial

WLFI is trending as investors debate whether the token is a legitimate DeFi opportunity or a high-risk scam amid ongoing lawsuits, governance votes, and significant price volatility. The community remains deeply polarized, with some bulls pointing to supply scarcity and potential token burns as catalysts for a recovery, while others emphasize the lack of utility and negative sentiment surrounding its association with high-profile figures.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillow is facing significant downward pressure as investors react to an antitrust lawsuit filed by the FTC and several states over allegations of anti-competitive practices in rental advertising. The community is actively debating the stock's future, with many weighing the impact of legal risks against Zillow's strategic integration of AI and its position as a dominant, profitable leader in the housing market.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl is currently trending due to intensifying scrutiny of the private credit sector, characterized by rising redemption requests and concerns regarding loan quality. Community discussions reflect a polarized sentiment, with some investors leveraging the price weakness as a deep-value opportunity while others warn of broader liquidity risks and potential systemic exposure to the software industry.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

Geo Group is experiencing significant momentum driven by government-backed ICE funding and the strategic expansion of detention capacity, with the community actively discussing a potential short squeeze fueled by high institutional ownership and speculative long-dated call options. Investors are closely tracking the company's role in federal immigration enforcement and the potential for asset sales or a government-led acquisition to unlock value.

Digimarc Corp. operates in the technology sector, focusing on digital watermarking and related digital identification solutions used across media, packaging, and product authentication markets. The company’s platform is aimed at enhancing product traceability, anti-counterfeiting measures, and supply-chain transparency for brand owners, retailers, and government entities. The company is headquartered in Beaverton, OR.

Digimarc Corp.

Digimarc Corporation

Digimarc Corporation is experiencing significant investor friction and scrutiny, driven by shareholder frustration over persistent leadership turnover and ongoing securities litigation. Community discourse is sharply divided between those bullish on the company's long-term potential in content provenance and gift card fraud protection, and vocal critics who argue the company has suffered from chronic underperformance and a lack of executive transparency.

Chip

Chip is trending as investors debate its role as a GPU-backed lending protocol amid significant price volatility and ongoing arguments between those betting on its AI infrastructure utility and others calling it a pump-and-dump scheme. The community is actively tracking its protocol fees and loan pipeline while speculating on whether recent price action represents a bear trap or a continued downward trend.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Investors are closely monitoring Oatly due to rumors of a potential China carve-out deal, which community members believe could significantly improve the balance sheet and unlock value. Despite frustration over stagnant price action, the discussion remains focused on optimistic long-term growth prospects, strong brand positioning, and the anticipation of upcoming quarterly results.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Approves KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEXTM (pembrolizumab and berahyaluronidase alfa-pmph), Mercks anti-PD-1 therapies, each in combination with WELIREG...

Can Bristol Myers' Growth Portfolio Offset Legacy Drug Declines?

BMY's growth portfolio now drives more than half of revenues, with strong gains from Reblozyl, Breyanzi and Cobenfy helping offset legacy drug declines.

Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?

Based on the average brokerage recommendation (ABR), Merck (MRK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

PAHC Stock: What's Driving Phibro's Animal Health Growth

Phibro Animal Health unit drove 74% of fiscal 2025 revenue, fueled by MFA, vaccines and global expansion, helping offset pressure in other businesses.

Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing

In the closing of the recent trading day, Merck (MRK) stood at $120.76, denoting a +1.4% move from the preceding trading day.

Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines

Pharma and biotech dealmaking is surging in 2026 as companies pursue acquisitions to expand pipelines, strengthen portfolios and drive growth.

The Zacks Analyst Blog Highlights Merck, The Southern, Lumentum and Peoples Bancorp of North Carolina

Merck, Southern Company, Lumentum and Peoples Bancorp of North Carolina are highlighted for growth drivers, performance and key risks.

Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

Is PAHC Undervalued at 10x Earnings vs Peers?

Phibro trades near 10x forward earnings vs higher peer multiples as strong Q3 beat, margin gains and 2026 guidance support a modest upside case.

Merck Animal Health To Acquire TARGAN To Expand Poultry Technology Portfolio

(RTTNews) - Merck Animal Health, a division of Merck & Co. (MRK), on Thursday announced a definitive agreement to acquire TARGAN, a privately held developer of biodevice solutions for the poultry industry, for undisclosed consideration...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Equity

Bearish Sentiment

Track MRK stock price, charts, news and real-time market activity on Stocktwits. Join the MRK message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Merck & Co Inc stock.

MRKMerck & Co Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MRK News